Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine—A Randomized Phase II Trial

This study is an investigator-initiated randomized phase II trial focusing on the treatment of advanced biliary tract cancer with either oxaliplatin 50 mg/m(2) and gemcitabine 1000 mg/m(2) on day 1 in a two-week cycle with capecitabine 650 mg/m(2) twice-daily continuously or cisplatin 25 mg/m(2) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Markussen, Alice, Jensen, Lars Henrik, Diness, Laura Vittrup, Larsen, Finn Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409144/
https://www.ncbi.nlm.nih.gov/pubmed/32698410
http://dx.doi.org/10.3390/cancers12071975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409144/
https://www.ncbi.nlm.nih.gov/pubmed/32698410
http://dx.doi.org/10.3390/cancers12071975

Ejemplares similares